Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Metastatic Non-hematologic Malignancies × vatalanib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Prostatic Neoplasms 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Metastatic Non-hematologic Malignancies 1 Mesothelioma, Malignant 1 Melanoma 1 Lymphoma, Large B-Cell, Diffuse 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

vatalanib 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00358163 2022-04-29

Trial of PTK787/ZK 222584 Plus Paclitaxel

Dana-Farber Cancer Institute

Phase 1 Terminated

Metastatic Non-hematologic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡